Description

ViLon 20mg × 10 vials

A synthetic short peptide studied for bioregulatory peptide research, immune-system models, thymus-related pathways, cellular aging research, gene-expression mechanisms, inflammatory response, and broader longevity-related protocols.

Product Overview

Compound: ViLon / Lys-Glu
Strength: 20 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 20 mg
BAC water: 2 mL
Amount per unit: 100 mcg per unit

Research Dose

Protocol dependent.

Notes

ViLon is described as a synthetic dipeptide composed of lysine and glutamic acid. It is commonly discussed within bioregulatory peptide research, especially in relation to thymus-associated immune signaling, cellular regulation, and age-related immune-function models.

Research literature has examined ViLon in connection with gene-expression modulation, immune-cell activity, thymic peptide pathways, inflammatory response regulation, and cellular aging-related mechanisms.

ViLon is primarily associated with bioregulatory and longevity-related research. It should not be treated as a standard therapeutic product, supplement, or general wellness peptide.

Most available evidence comes from laboratory, animal, and limited clinical-context research. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.